PSTX logo

Poseida Therapeutics (PSTX) Company Overview

Profile

Full Name:

Poseida Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 10, 2020

Indexes:

Not included

Description:

Poseida Therapeutics (PSTX) is a biotechnology company focused on developing innovative cell therapies for cancer and other diseases. They use advanced technologies to create personalized treatments that harness the power of the immune system, aiming to improve patient outcomes and provide new options for difficult-to-treat conditions.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 7, 2025

Recent annual earnings:

Mar 7, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 26, 24 William Blair
Market Perform
Nov 26, 24 HC Wainwright & Co.
Neutral
Nov 26, 24 BTIG
Neutral
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 30, 24 HC Wainwright & Co.
Buy
Oct 17, 24 HC Wainwright & Co.
Buy
Aug 6, 24 HC Wainwright & Co.
Buy
Jul 25, 24 HC Wainwright & Co.
Buy
May 22, 24 HC Wainwright & Co.
Buy

Screeners with PSTX included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Similar stocks

FAQ

  • What is the ticker symbol for Poseida Therapeutics?
  • Does Poseida Therapeutics pay dividends?
  • What sector is Poseida Therapeutics in?
  • What industry is Poseida Therapeutics in?
  • What country is Poseida Therapeutics based in?
  • When did Poseida Therapeutics go public?
  • Is Poseida Therapeutics in the S&P 500?
  • Is Poseida Therapeutics in the NASDAQ 100?
  • Is Poseida Therapeutics in the Dow Jones?
  • When was Poseida Therapeutics's last earnings report?
  • When does Poseida Therapeutics report earnings?
  • Should I buy Poseida Therapeutics stock now?

What is the ticker symbol for Poseida Therapeutics?

The ticker symbol for Poseida Therapeutics is NASDAQ:PSTX

Does Poseida Therapeutics pay dividends?

No, Poseida Therapeutics does not pay dividends

What sector is Poseida Therapeutics in?

Poseida Therapeutics is in the Healthcare sector

What industry is Poseida Therapeutics in?

Poseida Therapeutics is in the Biotechnology industry

What country is Poseida Therapeutics based in?

Poseida Therapeutics is headquartered in United States

When did Poseida Therapeutics go public?

Poseida Therapeutics's initial public offering (IPO) was on July 10, 2020

Is Poseida Therapeutics in the S&P 500?

No, Poseida Therapeutics is not included in the S&P 500 index

Is Poseida Therapeutics in the NASDAQ 100?

No, Poseida Therapeutics is not included in the NASDAQ 100 index

Is Poseida Therapeutics in the Dow Jones?

No, Poseida Therapeutics is not included in the Dow Jones index

When was Poseida Therapeutics's last earnings report?

Poseida Therapeutics's most recent earnings report was on Mar 7, 2025

When does Poseida Therapeutics report earnings?

The date for Poseida Therapeutics's next earnings report has not been announced yet

Should I buy Poseida Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions